Printer Friendly

INTERNATIONAL MUREX TECHNOLOGIES CORPORATION CLOSES UNIT OFFERING

 NORCROSS, Ga., July 16 /PRNewswire/ -- International Murex Technologies Corporation (IMTC) (AMEX: MXX; TSE) announced today that it has closed the sale of 710,800 units at U.S. $5.25 per unit to purchasers arranged through Yorkton Institutional Group, a division of Yorkton Securities, Inc., completing the financing announced on July 7.
 A unit consists of one common share and a half of a share purchase warrant and these units were placed outside the U.S. to non-U.S. persons and institutions. The gross proceeds of the offering was U.S. $3,731,700 and will be used for general corporate purposes.
 The 710,800 new common shares and purchase warrants issued in this sale are subject to Securities and Exchange Commission and Ontario Securities Commission regulations which provide that the securities may not be traded in North America until Aug. 24. One full warrant allows the holder to purchase one common share for U.S. $5.775 through July 17.
 IMTC is a medical diagnostic products company dedicated to the research, manufacture and marketing of products for the detection, monitoring and screening of infectious diseases and other medical conditions. IMTC has an FDA-licensed manufacturing facility in Norcross, Ga. In addition, the company's European subsidiary, Murex Diagnostics, of Dartford, England, was one of the first U.K.-based in vitro diagnostic companies certified under the ISO 9001 regulations covering the design, manufacture and distribution of medical diagnostic products. IMTC employs approximately 635 people worldwide. The company manufactures and markets more than 600 products including a range of mass screening diagnostic tests and its unique rapid (10 minute) SUDS(R) tests for the detection of antibodies to HIV-1 and HIV-2.
 -0- 7/16/93
 /CONTACT: C. Robert Cusick, vice chairman and chief executive officer, or Marcia M. Young, director of Corporate Communications of International Murex, 800-322-1332 or 404-662-0660/
 (MXX)


CO: International Murex Corporation ST: Georgia IN: MTC SU: OFR

BR-BN -- AT004 -- 2409 07/16/93 10:54 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 16, 1993
Words:327
Previous Article:MEDIQ ANNOUNCES RECEIPT OF CONSENT FROM BONDHOLDERS TO PERMIT DISTRIBUTION OF MENTAL HEALTH MANAGEMENT STOCK
Next Article:UNIFI AND PIONEER YARNS ANNOUNCE SIGNING OF MERGER AGREEMENT
Topics:


Related Articles
INTERNATIONAL MUREX TECHNOLOGIES ANNOUNCES EURO-EQUITY FINANCING
AMEX OPENS OPTIONS TRADING ON BALLY GAMING INTERNATIONAL AND AMEX-LISTED INTERNATIONAL MUREX TECHNOLOGIES
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION REPORTS NO REASON FOR STOCK DECLINE
INTERNATIONAL MUREX TECHNOLOGIES NAMES FORMER SYNTEX DIVISION DIRECTOR TO HEAD INTERNATIONAL COMMERCIAL OPERATIONS
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION ADVISES HOLDERS OF UPCOMING WARRANT EXPIRATION
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION ANNOUNCES STOCK REPURCHASE UP TO 5% OF OUTSTANDING COMMON SHARES
INTERNATIONAL MUREX TECHNOLOGIES TO BEGIN TRADING ON NASDAQ JUNE 1, 1995
INTERNATIONAL MUREX'S SUBSIDIARY ENTERS VOLUNTARY LIQUIDATION
Abbott Laboratories to Acquire International Murex Technologies Corporation For $234 Million or $13 Per Share

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters